Synerkine Pharma Raises EUR3.3 Million in Series A Financing - Business Wire
Synerkine Pharma Raises EUR3.3 Million in Series A Financing Business Wire
Synerkine Pharma Raises EUR3.3 Million Series A to advance novel fusion proteins for the treatment of inflammatory, neuropathic & osteoarthritic pain.
Comments
Post a Comment